View of Outcomes of Factor Xa Inhibitor-based Regimens Versus Dual Antiplatelet Therapy in Managing Infrageniculate Critical Limb Ischemia Post Angioplasty

Return to Article Details Outcomes of Factor Xa Inhibitor-based Regimens Versus Dual Antiplatelet Therapy in Managing Infrageniculate Critical Limb Ischemia Post Angioplasty Download Download PDF